Tuberculosis, Multidrug-Resistant

Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS.

Year introduced: 1994

PubMed search builder options

Subheadings:

Restrict to MeSH Major Topic.

Do not include MeSH terms found below this term in the MeSH hierarchy.

Tree Number(s): C01.150.252.410.040.552.846.775

MeSH Unique ID: D018088

Entry Terms:

• Multidrug-Resistant Tuberculosis
• Tuberculosis, Multidrug Resistant
• Tuberculosis, MDR
• MDR Tuberculosis
• Tuberculosis, Multi-Drug Resistant
• Multi-Drug Resistant Tuberculosis
• Tuberculosis, Multi Drug Resistant
• Tuberculosis, Drug-Resistant
• Drug-Resistant Tuberculosis
• Tuberculosis, Drug Resistant

Previous Indexing:

• Drug Resistance, Microbial (1990-1993)
• Tuberculosis (1990-1993)
• Tuberculosis, Pulmonary (1990-1993)

See Also:

• Drug Resistance, Multiple, Bacterial

All MeSH Categories
Diseases Category
Infections
Bacterial Infections and Mycoses
Bacterial Infections
Gram-Positive Bacterial Infections
Actinomycetales Infections
Mycobacterium Infections
Tuberculosis
Tuberculosis, Multidrug-Resistant
Extensively Drug-Resistant Tuberculosis